Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Discovery of Novel, First-in-Class Allosteric Modulators of MALT1 Scaffolding Function with Differentiated Pharmacology for NFκB-Driven Malignancies

Yi Yao, Yingzhi Bi, Huadong Sun, Kevin Ling, Huili Xia, Jun Kuai, Patrick DePaolo, Virginie Lafont, David Diller, Ara Aslanian, Samira Jaeger, Joe Wahle, Wei Liu, Ken Carson, Timothy Reilly, Gerry Harriman, Fang Wang

Blood (2023) 142 (Supplement 1): 52.

https://doi.org/10.1182/blood-2023-172899

Published: 2023

Journal Articles

The American Society of Hematology Clinical Research Training Institute is associated with high retention in academic hematology

Allison A. King, Sara K. Vesely, Jessica Elwood, Joe Basso, Ken Carson, Lillian Sung

Blood (2016) 128 (25): 2881–2885.

https://doi.org/10.1182/blood-2016-06-724211

Published: 2016

Journal Articles

Waiting for Godot: Thirty-Six Month Follow-Up on Accelerated FDA Approval of Drugs To Treat Hematologic Malignancies.

Veena Shankaran, MD, June McKoy, MD, MPH, JD, Ben Djulbegovic, MD, PhD, Allison Lyons, BA, Ken Carson, MD, Cara Tigue, BA, Neal Dandade, BA, Martin Tallman, MD, Oliver Sartor, MD, Charles Bennett, MD, PhD, MPP

Blood (2007) 110 (11): 3340.

https://doi.org/10.1182/blood.V110.11.3340.3340

Published: 2007

Journal Articles

Counterfeit Epoetin: A Review of MedWatch Data.

Dennis W. Raisch, PhD, Charles L. Bennett, MD, PhD, MPP, Jonathan Nebeker, MD, Rita Jakiche, MS, Ken Carson, MD

Blood (2005) 106 (11): 2251.

https://doi.org/10.1182/blood.V106.11.2251.2251

Published: 2005

Journal Articles

Preliminary Findings from the Prospective Multicenter Surveillance, Epidemiology and Risk Factors for Thrombotic Thrombocytopenic Purpura (SERF-TTP) Study.

Anaadriana Zakarija, MD, Nicholas Bandarenko, MD, Dilip K. Pandey, Hau Kwaan, MD, PhD, Kathryn McCaffrey, BA, Denise Finley, BA, Ken Carson, MD, Paul Yarnold, PhD, Charles L. Bennett, MD, PhD

Blood (2004) 104 (11): 855.

https://doi.org/10.1182/blood.V104.11.855.855

Published: 2004

NARROW

Discovery of Novel, First-in-Class Allosteric Modulators of MALT1 Scaffolding Function with Differentiated Pharmacology for NFκB-Driven Malignancies

The American Society of Hematology Clinical Research Training Institute is associated with high retention in academic hematology

Waiting for Godot: Thirty-Six Month Follow-Up on Accelerated FDA Approval of Drugs To Treat Hematologic Malignancies.

Counterfeit Epoetin: A Review of MedWatch Data.

Preliminary Findings from the Prospective Multicenter Surveillance, Epidemiology and Risk Factors for Thrombotic Thrombocytopenic Purpura (SERF-TTP) Study.

Email alerts

ASH Publications

American Society of Hematology

Discovery of Novel, First-in-Class Allosteric Modulators of MALT1 Scaffolding Function with Differentiated Pharmacology for NFκB-Driven Malignancies

The American Society of Hematology Clinical Research Training Institute is associated with high retention in academic hematology

Waiting for Godot: Thirty-Six Month Follow-Up on Accelerated FDA Approval of Drugs To Treat Hematologic Malignancies.

Counterfeit Epoetin: A Review of MedWatch Data.

Preliminary Findings from the Prospective Multicenter Surveillance, Epidemiology and Risk Factors for Thrombotic Thrombocytopenic Purpura (SERF-TTP) Study.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only